These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29925382)

  • 1. A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer.
    Zhang Q; Shan F; Li Z; Gao J; Li Y; Shen L; Ji J; Lu M
    J Transl Med; 2018 Jun; 16(1):171. PubMed ID: 29925382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.
    Li W; Zhang X; Yang Y; Lin J; Zhou K; Sun R; Dang C; Diao D
    Sci Rep; 2024 Jun; 14(1):12758. PubMed ID: 38830909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer.
    Uenosono Y; Arigami T; Kozono T; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirata M; Arima H; Funasako Y; Kijima Y; Nakajo A; Okumura H; Ishigami S; Hokita S; Ueno S; Natsugoe S
    Cancer; 2013 Nov; 119(22):3984-91. PubMed ID: 23963829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
    Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
    Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
    Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
    JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
    Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
    PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
    Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
    BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.
    Okabe H; Tsunoda S; Hosogi H; Hisamori S; Tanaka E; Tanaka S; Sakai Y
    Ann Surg Oncol; 2015 Nov; 22(12):3954-61. PubMed ID: 25777087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy.
    Thalgott M; Rack B; Horn T; Heck MM; Eiber M; Kübler H; Retz M; Gschwend JE; Andergassen U; Nawroth R
    Anticancer Res; 2015 Oct; 35(10):5679-85. PubMed ID: 26408743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.
    Sclafani F; Smyth E; Cunningham D; Chau I; Turner A; Watkins D
    Clin Colorectal Cancer; 2014 Jun; 13(2):94-9. PubMed ID: 24332356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer.
    Reeh M; Effenberger KE; Koenig AM; Riethdorf S; Eichstädt D; Vettorazzi E; Uzunoglu FG; Vashist YK; Izbicki JR; Pantel K; Bockhorn M
    Ann Surg; 2015 Jun; 261(6):1124-30. PubMed ID: 25607767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
    Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
    Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
    Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
    Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.